| 摘要 |
FIELD: pharmacology; biotechnology. ^ SUBSTANCE: invention concerns biotechnology and represents a vector of carrying over of DNA which contains the sequence coding the p185neu fragment. The given vector is a part of a pharmaceutical composition for use in preventive or therapeutic treatment of patients with risk of development p185-positive tumours or the patients having primary tumours, metastasises or relapses p185neu-expressing tumours. ^ EFFECT: obtaining of the new more effective pharmaceutical compositions for preventive maintenance and treatment of p185neu-positive tumours. ^ 11 cl, 14 dwg, 1 tbl, 2 ex |
